| 日期 | 描述 |
|---|---|
| 2026-06-10 | [ilnd-1:2026-cv-03999-00017] Amended Complaint |
| 2026-05-01 | [ilnd-1:2026-cv-03999-00012] Order on Motion for Discovery |
| 2026-04-10 | [ilnd-1:2026-cv-03999-00005] Discovery |
| 2026-04-10 | [ilnd-1:2026-cv-03999-00001-001] Exhibit A - Plan Document |
Huang v. the Partnerships and Unincorporated Associations identified on Schedule A
1:25-cv-12824 Kral v. Association of Casualty and Surety Companies et al
2:24-cv-02044 JEWS AT HAVERFORD et al v. THE CORPORATION OF HAVERFORD COLLEGE
2:26-cv-03254 THE ESTATE OF MAX AND JOICE ELIASON et al v. THE CORPORATION OF THE PRESIDENT OF THE CHURCH OF JESUS CHRIST OF LATTER-DAY SAINTS et al
1:22-cv-08521 Griffin v. Corporation Counsel et al
1:26-cv-23832 ALLEN v. Corporation
5:26-cv-00104 Wilson v. Partnership Property Management et al
7:25-cv-01614 Barbaglia et al v. Lend Lease (US) Public Partnerships, LLC et al
6:25-cv-00222 Doe v. Corporation of The Presiding Bishop of the Church of Jesus Christ of Latter-Day Saints et al
4:25-cv-00917 United States of America v. Undetermined quantities of dietary supplement products that are labeled or otherwise appear to contain 7-hydroxymitragynine, as identified in Exhibit A, located at 1501 Iron Street, North Kansas City et al
Huang v. the Partnerships and Unincorporated Associations identified on Schedule A
1:25-cv-12824 Kral v. Association of Casualty and Surety Companies et al
2:24-cv-02044 JEWS AT HAVERFORD et al v. THE CORPORATION OF HAVERFORD COLLEGE
2:26-cv-03254 THE ESTATE OF MAX AND JOICE ELIASON et al v. THE CORPORATION OF THE PRESIDENT OF THE CHURCH OF JESUS CHRIST OF LATTER-DAY SAINTS et al
1:22-cv-08521 Griffin v. Corporation Counsel et al
1:26-cv-23832 ALLEN v. Corporation
5:26-cv-00104 Wilson v. Partnership Property Management et al
7:25-cv-01614 Barbaglia et al v. Lend Lease (US) Public Partnerships, LLC et al
6:25-cv-00222 Doe v. Corporation of The Presiding Bishop of the Church of Jesus Christ of Latter-Day Saints et al
4:25-cv-00917 United States of America v. Undetermined quantities of dietary supplement products that are labeled or otherwise appear to contain 7-hydroxymitragynine, as identified in Exhibit A, located at 1501 Iron Street, North Kansas City et al
